ICL集团

最新新闻

• 评级变动
  Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $5.4
  \u5e02\u573a\u8d44\u8baf · 2026/4/3
• 评级变动
  Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $6.15
  \u5e02\u573a\u8d44\u8baf · 2026/1/14
• 评级变动
  Barclays Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $7
  \u5e02\u573a\u8d44\u8baf · 2026/5/18
• 评级变动
  BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $6.75
  \u5e02\u573a\u8d44\u8baf · 2025/11/13
• 评级变动
  Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $5.8
  \u5e02\u573a\u8d44\u8baf · 2025/11/25
• 评级变动
  BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $6.5
  \u5e02\u573a\u8d44\u8baf · 2026/5/20
• 评级变动
  Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $5.6
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $5.6
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• 评级变动
  Barclays Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $7
  \u5e02\u573a\u8d44\u8baf · 2025/8/13
• KingMed Diagnostics (603882): The ICL industry is gradually stabilizing, and the company's profitability has improved significantly.
  Citic Securities · 2026/9/30
• 评级变动
  Barclays Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $6
  \u5e02\u573a\u8d44\u8baf · 2026/7/27
• Barclays Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $6
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• ICL Group Q2 Adj. EPS $0.12 Beats $0.10 Estimate, Sales $2.135B Beat
  Benzinga · 2026/8/5
• 公司公告
  ICL Group | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Harel Insurance Investments & Financial Services Ltd.(5.4%)
  SEC · 2024/1/30
• 公司公告
  ICL Group | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altshuler-Shaham Ltd.(5.0%),Gilad Altshuler(5.0%), etc.
  SEC · 2023/1/17
• 公司公告
  ICL Group | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Phoenix Holdings Ltd.(5.02%)
  SEC · 2023/12/28
• 公司公告
  ICL Group | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Israel Corporation Ltd. : 000000000(43.98%)
  SEC · 2023/2/4
• Morgan Stanley Initiates ICL Group(ICL.US) With Hold Rating, Announces Target Price $5.75
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $6
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• 公司公告
  Imperium Crown: Asset Acquisitions and Disposals-Dissolution of Dormant Wholly-Owned Subsidiary - ICL Land Sdn. Bhd.
  SGX · 2025/6/18

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。